Effects of dietary phospholipid level in cobia (Rachycentron canadum) larvae: growth, survival, plasma lipids and enzymes of lipid metabolism.
A study was conducted to determine the effects of dietary phospholipid (PL) levels in cobia (Rachycentron canadum) larvae with regard to growth, survival, plasma lipids and enzymes of lipid metabolism. Fish with an average weight of 0.4 g were fed diets containing four levels of PL (0, 20, 40 and 80 g kg(-1)dry matter: purity 97%) for 42 days. Final body weight (FBW), weight gain (WG) and survival ratio were highest in the 8% PL diet group and mortality was highest in PL-free diet group. We examined the activities of lipoprotein lipase (LPL) and hepatic lipase (HL) in liver, lecithin-cholesterolacyltransferase (LCAT) in plasma as well as plasma lipids and lipoprotein. LCAT activity showed a decrease of more than two-fold in PL-supplemented diet groups compared with the PL-free diet group. HL activity was highest in the 8% PL diet group and the other three groups showed no difference. LPL activity was significantly higher in the PL-supplemented diet groups than in the PL-free diet group. The dietary intervention significantly increased plasma phospholipids and total cholesterol (TC) levels, and the higher free cholesterol (FC) level contributed to the TC level. However, the fish fed PL exhibited a significantly decreased plasma triglyceride (TG) level. The lipoprotein fractions were also affected significantly by the PL. The PL-supplemented diet groups had significantly higher high-density lipoprotein (HDL) compared with the PL-free diet group, but showed a marked decrease in very low-density lipoprotein (VLDL). The results suggested that PL could modify plasma lipoprotein metabolism and lipid profile, and that the optimal dietary PL level may well exceed 80 g kg(-1) for cobia larvae according to growth and survival.
Niu
J
J
Nutrition Laboratory, Institute of Aquatic Economic Animals, School of Life Science, Sun Yat-sen University, 135 Xin'gang Xi Road, Guangzhou, 510275, PR China.
Liu
Y J
YJ
Tian
L X
LX
Mai
K S
KS
Yang
H J
HJ
Ye
C X
CX
Zhu
Y
Y
D000818:Animals; D004032:Diet / Q000662:veterinary*; D004041:Dietary Fats / Q000494:pharmacology*; D004798:Enzymes / Q000378:metabolism*; D007814:Larva / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development / Q000378:metabolism; D050356:Lipid Metabolism / Q000187:drug effects*; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D010473:Perciformes / Q000254:growth & development / Q000378:metabolism / Q000502:physiology*; D010743:Phospholipids / Q000008:administration & dosage / Q000494:pharmacology*; D010949:Plasma / Q000187:drug effects / Q000201:enzymology; D016019:Survival Analysis
D004041:Dietary Fats; D004798:Enzymes; D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids